These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11831108)

  • 1. The metabolic syndrome, smoking, and antibodies to oxidized LDL in 58-year-old clinically healthy men.
    Fagerberg B; Bokemark L; Hulthe J
    Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4):227-35. PubMed ID: 11831108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesteryl ester transfer protein in metabolic syndrome.
    Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
    Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men.
    Sjögren P; Fredrikson GN; Rosell M; de Faire U; Hamsten A; Nilsson J; Hellenius ML; Fisher RM
    Metabolism; 2008 Mar; 57(3):362-6. PubMed ID: 18249208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients.
    Myara I; Alamowitch C; Michel O; Heudes D; Bariety J; Guy-Grand B; Chevalier J
    Obes Res; 2003 Jan; 11(1):112-20. PubMed ID: 12529493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein particle size, insulin resistance, and proinsulin in a population sample of 58-year-old men.
    Fagerberg B; Hulthe J; Bokemark L; Wikstrand J
    Metabolism; 2001 Jan; 50(1):120-4. PubMed ID: 11172485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism.
    Sämpi M; Veneskoski M; Ukkola O; Kesäniemi YA; Hörkkö S
    J Clin Endocrinol Metab; 2010 May; 95(5):2467-75. PubMed ID: 20332251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
    Dotevall A; Hulthe J; Rosengren A; Wiklund O; Wilhelmsen L
    Clin Sci (Lond); 2001 Nov; 101(5):523-31. PubMed ID: 11672458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins.
    Damoiseaux J; Jeyasekharan AD; Theunissen R; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():163-9. PubMed ID: 16014530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating oxidized LDL is associated with increased levels of cell-adhesion molecules in clinically healthy 58-year old men (AIR study).
    Hulthe J; Fagerberg B
    Med Sci Monit; 2002 Mar; 8(3):CR148-52. PubMed ID: 11887026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body-mass index, waist-size, waist-hip ratio and cardiovascular risk factors in urban subejcts.
    Gupta R; Rastogi P; Sarna M; Gupta VP; Sharma SK; Kothari K
    J Assoc Physicians India; 2007 Sep; 55():621-7. PubMed ID: 18051732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study.
    Han TS; Williams K; Sattar N; Hunt KJ; Lean ME; Haffner SM
    Obes Res; 2002 Sep; 10(9):923-31. PubMed ID: 12226141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL; Elofsson S; Brismar K
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study).
    Sigurdardottir V; Fagerberg B; Hulthe J
    J Intern Med; 2002 Nov; 252(5):440-7. PubMed ID: 12528762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.
    Tonstad S; Hjermann I
    J Cardiovasc Risk; 2003 Apr; 10(2):129-35. PubMed ID: 12668910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol consumption is directly associated with circulating oxidized low-density lipoprotein.
    Schroder H; Marrugat J; Fíto M; Weinbrenner T; Covas MI
    Free Radic Biol Med; 2006 Apr; 40(8):1474-81. PubMed ID: 16631537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria.
    Gazi I; Tsimihodimos V; Filippatos T; Bairaktari E; Tselepis AD; Elisaf M
    Metabolism; 2006 Jul; 55(7):885-91. PubMed ID: 16784959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A; Young IS; Wisdom GB
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.